YS BIOPHARMA CO LTD (YS) Stock Balance Sheet
NASDAQ:YS • KYG9845F1090
Current stock price
1.02 USD
+0.11 (+12.45%)
At close:
1.07 USD
+0.05 (+4.9%)
After Hours:
| 2023 (2023-3-31) | 2022 (2021-12-31) | 2021 (2020-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|
| ASSETS | |||||||
| Current Assets | |||||||
| Cash | 370.11M | 885.20K | 885.20K | N/A | |||
| Marketable Securities | 4.34M | 2.81M | N/A | N/A | |||
| Receivables | 468.09M | 312.74M | N/A | N/A | |||
| Inventories | 185.38M | 166.51M | N/A | N/A | |||
| Other Current Assets | 8.06M | 141.68K | 141.68K | N/A | |||
| Total Current Assets | 1.04B | 1.03M | 1.03M | N/A | |||
| Non-Current Assets | |||||||
| PPE Net | 582.89M | 565.00M | N/A | N/A | |||
| Investments And Advances | N/A | 200.01M | 200.01M | N/A | |||
| Intangibles | 78.06M | 80.72M | N/A | N/A | |||
| Other Non-Current Assets | 22.83M | 0.00 | 91.37K | 91.37K | |||
| Total Non-Current Assets | 683.77M | 200.01M | -935.51K | N/A | |||
| TOTAL ASSETS | 1.72B | 201.03M | 91.37K | 91.37K | |||
| LIABILITIES | |||||||
| Current Liabilities | |||||||
| Short Term Debt | 0.00 | 0.00 | 5.01K | 5.01K | |||
| Current Portion Of LT Debt. | 193.74M | 111.73M | N/A | N/A | |||
| Accrued Expenses | 266.17M | 142.63K | 65.00K | 65.00K | |||
| Accounts Payable | 80.44M | 30.81M | N/A | N/A | |||
| Other Current Liabilities | 118.42M | 105.65M | N/A | N/A | |||
| Total Current Liabilities | 658.76M | 142.63K | 70.01K | 70.01K | |||
| Non-Current Liabilities | |||||||
| Long Term Debt | 293.79M | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 38.75M | 20.21M | 20.21M | N/A | |||
| Total Non-Current Liabilities | 332.54M | 20.21M | 0.00 | 0.00 | |||
| TOTAL LIABILITIES | 991.30M | 20.35M | 70.01K | 70.01K | |||
| SHAREHOLDERS' EQUITY | |||||||
| Retained Earnings | -1.87B | -19.32M | -3.64K | -3.64K | |||
| Additional Paid In Capital | 2.66B | 0.00 | 24.35K | 24.35K | |||
| Common Shares | 12.30K | 200.00M | 650.00 | 650.00 | |||
| Other Shareholders' Equity | -54.41M | 83.09M | N/A | N/A | |||
| Shares Outstanding | 93.06M | 25.75M | 25.75M | 25.75M | |||
| Tangible Book Value per Share | 6.99 | 7.02 | 0.00 | 0.00 | |||
| Total Shareholders' Equity | 728.45M | 180.68M | 21.36K | 21.36K | |||
| TOTAL LIABILITIES AND EQUITY | 1.72B | 201.03M | 91.37K | 91.37K | |||
| Statistics | |||||||
| Debt/Equity | 0.40 | N/A | N/A | N/A | |||
| Current Ratio | 1.57 | 7.20 | 14.67 | N/A | |||
| Return On Assets (ROA) | -16.48% | -0.27% | -3.98% | -3.98% | |||
| Return On Equity (ROE) | -38.91% | -0.30% | -17.04% | -17.04% | |||
All data in CNY , ROIC based on taxRate of 0.21